Authors: | Cheung, N. K. V.; Kushner, B. H.; Kramer, K. |
Article Title: | Monoclonal antibody-based therapy of neuroblastoma |
Abstract: | The curative potential of mAbs in the treatment of patients with metastatic neuroblastoma is increasingly evident. The idiotype network appears to represent one component of a complex mechanism for success with mAb-based immunotherapy. Ongoing strategies to modify or reconstruct mAbs, to engage them with cytokines, or to unite them with T cells open new avenues for harnessing the unique forces of the immune system against some of the most deadly pediatric cancers. |
Keywords: | signal transduction; cancer chemotherapy; cancer survival; child; treatment outcome; unclassified drug; clinical trial; drug tolerability; review; doxorubicin; cancer radiotherapy; radiation dose; cancer staging; interleukin 2; cancer immunotherapy; immune system; etoposide; neuropathy; granulocyte macrophage colony stimulating factor; cyclophosphamide; vincristine; protein interaction; childhood cancer; monoclonal antibody; fever; hypotension; cancer regression; antibodies, monoclonal; immunotherapy; neuroblastoma; radiopharmaceutical agent; nausea and vomiting; drug half life; radioimmunotherapy; clinical trials; monoclonal antibody 3f8; monoclonal antibody 3f8 i 131; antigen antibody complex; chimeric antibody; antibodies, anti-idiotypic; immunotherapy, active; humans; human; priority journal; chimeric antibody ch 14.18; monoclonal antibody 14 g2a; monoclonal antibody i 131 |
Journal Title: | Hematology/Oncology Clinics of North America |
Volume: | 15 |
Issue: | 5 |
ISSN: | 0889-8588 |
Publisher: | Elsevier Inc. |
Date Published: | 2001-10-01 |
Start Page: | 853 |
End Page: | 864 |
Language: | English |
PUBMED: | 11765377 |
PROVIDER: | scopus |
DOI: | 10.1016/s0889-8588(05)70255-0 |
DOI/URL: | |
Notes: | Export Date: 21 May 2015 -- Source: Scopus |